Coagulation studies in patients treated with defibrase.
D000818:Animals; D000991:Antithrombins / Q000378:metabolism; D005165:Factor V / Q000378:metabolism; D005169:Factor VIII / Q000378:metabolism; D005170:Factor X / Q000378:metabolism; D005174:Factor XII / Q000378:metabolism; D005176:Factor XIII / Q000378:metabolism; D005337:Fibrin / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism*; D006801:Humans; D007122:Immunoelectrophoresis; D008259:Macroglobulins / Q000378:metabolism; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D010958:Plasminogen / Q000378:metabolism*; D011516:Prothrombin / Q000378:metabolism; D012911:Snakes; D013917:Thrombin / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy; D014688:Venoms / Q000627:therapeutic use*
D000991:Antithrombins; D008259:Macroglobulins; D014688:Venoms; D005165:Factor V; D011516:Prothrombin; D005169:Factor VIII; D005170:Factor X; D005174:Factor XII; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D005176:Factor XIII; D010447:Peptide Hydrolases; D013917:Thrombin